ArticleActive
Billing and Coding: Multimarker Serum Tests Related to Ovarian Cancer Testing
A57020
National Government Services, Inc. (J06)
Effective: July 1, 2020
Updated: December 31, 2025
Policy Summary
This billing and coding article provides Medicare billing requirements and coding guidance for multimarker serum tests related to ovarian cancer testing; it references specific CPT codes (81500 for ROMA, 81503 for OVA1, 0003U for OVERA). Claims must include a valid ICD-10-CM diagnosis that best describes the condition, and when applicable must report the referring/ordering physician's name and NPI; providers should also review NCCI and OPPS edits before billing.
Coverage Criteria Preview
Key requirements from the full policy
"Multimarker serum tests related to the evaluation or monitoring of ovarian cancer may be billed under this policy in accordance with the applicable Local Coverage Determination (LCD)."
Sign up to see full coverage criteria, indications, and limitations.